Medically reviewed by the clinical team at OC Weight Loss and Medspa. Last updated May 18, 2026.
The short answer: The strongest evidence for recovery-supportive peptides sits with the growth-hormone secretagogues (Ipamorelin, Sermorelin, CJC-1295) for sleep and lean-tissue support and with NAD+ precursors for cellular energy and mitochondrial function. BPC-157 and TB-500 are popular in gym and biohacker circles, but they have no published human randomized trials, no FDA approval, and remain gray-market. At OC Weight Loss and Medspa we prescribe Ipamorelin and NAD+ under physician supervision; we do not offer BPC-157 or TB-500.
What does “peptides for recovery” actually mean?
“Recovery” is a soft word that covers four different physiological jobs: sleep quality, tissue repair (muscle, tendon, soft tissue), cellular energy (mitochondrial output, NAD+ pools, redox balance), and inflammation resolution. A peptide that helps one of these jobs is not automatically helpful for the others, and most of the supplement-shop hype collapses the categories into a single recovery promise.
This guide groups recovery peptides by which job they actually do, what the human evidence shows, and where the marketing has run ahead of the data. If you want the broader landscape — including weight-loss and longevity peptides — start with our peptide therapy guide.
How are recovery peptides categorized?
Best peptides for recovery: option-by-option
1. Ipamorelin — sleep, lean-tissue support
Ipamorelin is a selective growth-hormone-releasing peptide that prompts the pituitary to release endogenous GH in pulses that mimic the natural pattern, particularly during early sleep. The clinical signal that patients describe most often is deeper, less interrupted slow-wave sleep within two to four weeks. That sleep effect — not a dramatic muscle-building outcome — is the recovery mechanism worth taking seriously.
Unlike exogenous HGH, Ipamorelin works within the body’s feedback loop and does not blunt natural pituitary function at typical clinical doses. Compared with older secretagogues (GHRP-2, GHRP-6) it does not raise cortisol or prolactin. For a head-to-head with the most common alternative, see Ipamorelin vs Sermorelin.
2. Sermorelin and CJC-1295 — the longer-acting GH axis
Sermorelin is a GHRH analog with a long FDA history (originally approved for pediatric growth-hormone deficiency). CJC-1295 is a modified GHRH with a longer half-life. Both push the same axis as Ipamorelin from a different angle, and clinicians often combine a GHRH (Sermorelin or CJC-1295) with a GHRP (Ipamorelin) to widen the GH pulse.
The honest expectation: improved sleep quality, modest improvement in body composition over 3–6 months, and slow normalization of IGF-1 if it was low at baseline. These are not anabolic steroids. They will not transform a sedentary patient into an athlete.
3. NAD+ — mitochondrial energy and redox
NAD+ is technically a coenzyme, not a peptide, but it sits inside the same recovery conversation. NAD+ levels fall with age and with sustained metabolic stress. Replenishing NAD+ supports mitochondrial output, sirtuin signaling, and DNA-repair pathways. The clinical signal patients describe is steadier energy and faster recovery from physical or cognitive stress over a 4–8 week protocol.
NAD+ is delivered intravenously or by subcutaneous injection. The IV route gives faster onset but takes 60–120 minutes per session and can cause a flushing sensation. For mechanism and dosing context, see NAD injection benefits.
4. BPC-157 and TB-500 — what the marketing skips
BPC-157 (“Body Protection Compound”) and TB-500 (a fragment of thymosin beta-4) dominate the gray-market peptide conversation. Both have plausible mechanisms in animal and in-vitro models — angiogenesis, growth-factor recruitment, fibroblast migration — and both are marketed for tendon, ligament, gut, and connective-tissue healing.
The honest data picture: there are no published peer-reviewed human randomized controlled trials for either peptide in any healing indication. The FDA placed BPC-157 on its Category 2 “Bulk Drug Substances” list in 2023, which means it cannot be lawfully compounded by 503A pharmacies for office or patient use. We do not offer BPC-157 or TB-500. For the longer history and rationale, see our BPC-157 educational guide.
5. GHK-Cu — topical first, injectable a distant second
GHK-Cu is a copper tripeptide with decent dermatology evidence as a topical agent (wound healing, collagen support). The injectable form is far less studied. For most recovery goals, GHK-Cu is not the highest-yield choice; treat the topical and injectable forms as different products with different evidence bases.
What does the research show?
For the GH-secretagogue family, several human studies support modest sleep and body-composition effects when used under supervision. Tesamorelin (a long-acting GHRH analog) has FDA approval for HIV-associated lipodystrophy on the strength of its IGF-1 and visceral-fat data (Falutz et al., NEJM 2007). For NAD+, early human work suggests improved mitochondrial markers, though most of the strongest data is on the oral precursors NR and NMN rather than IV NAD+ (Martens et al., Nat Commun 2018).
For BPC-157 and TB-500, the published literature is overwhelmingly animal-model and in-vitro. The World Anti-Doping Agency added BPC-157 to its 2022 Prohibited List under S0 (non-approved substances) — a regulatory signal worth knowing if you compete in tested sport.
Who is a candidate for recovery peptide therapy?
- Adults 30+ with poor sleep architecture, slow recovery between training sessions, or low baseline energy
- Patients with documented suboptimal IGF-1 (only after labs)
- Perimenopausal and post-menopausal women whose recovery profile changed alongside hormonal shifts (often layered with HRT)
- Men with low testosterone whose energy/recovery has not fully normalized on TRT alone
- People who can commit to 3–6 months of consistent dosing and follow-up labs
Recovery peptides are not for: active cancer, untreated thyroid disease, pregnancy or breastfeeding, or patients unwilling to do baseline and follow-up labs. They are also not a substitute for sleep, protein intake, or resistance training — those three move the needle further than any injectable for most people.
How much do recovery peptides cost?
Pricing varies by peptide, dose, and supplier. Representative ranges for Orange County in 2026:
- Ipamorelin (with or without CJC-1295): ~$300–$500/month
- Sermorelin: ~$250–$450/month
- NAD+ IV: ~$300–$600 per session; protocols typically run 4–10 sessions
- NAD+ subcutaneous: ~$200–$350/month
Pricing is not the right place to economize — sourcing is. Always work with a clinic that uses a U.S. licensed 503A or 503B compounding pharmacy with traceable lot numbers. The “research peptide” market is unregulated and a known source of contamination.
What are the side effects?
- Ipamorelin / Sermorelin / CJC-1295: injection-site redness, transient hand tingling, water retention, vivid dreams in the first weeks. Monitor IGF-1 and fasting glucose.
- NAD+ IV: chest pressure, flushing, nausea if infused too quickly — managed by slowing the infusion rate.
- NAD+ subcutaneous: injection-site soreness, occasional bruising.
Our evidence-based stance
OC Weight Loss and Medspa offers Ipamorelin, Sermorelin, CJC-1295, and NAD+ under physician supervision with baseline and follow-up labs. We do not offer BPC-157 or TB-500. That position reflects the regulatory status of those substances and the absence of human RCT evidence — not an opinion about their theoretical biology, which we find interesting and incomplete.
FAQ
How fast do recovery peptides work?
Most patients on Ipamorelin or Sermorelin notice deeper sleep within 2–4 weeks. Body-composition and IGF-1 changes take 3–6 months. NAD+ effects on energy and clarity usually surface within the first 2–4 sessions if you are going to respond.
Are recovery peptides safe long-term?
The GH-secretagogue family has the longest clinical track record and is generally safe when prescribed with regular labs to monitor IGF-1, fasting glucose, and HbA1c. NAD+ has a shorter clinical history but a clean acute safety profile. We typically reassess every 90 days.
Can I take peptides if I am on TRT or GLP-1 medications?
Yes — these are commonly layered. Ipamorelin or Sermorelin pairs well with TRT for recovery and sleep. NAD+ is often used during GLP-1 therapy to support energy when caloric intake is reduced.
Why do you not offer BPC-157?
The FDA placed BPC-157 on its 503A Category 2 list in 2023, which means it cannot be lawfully compounded for office or patient use. There are also no published human randomized trials. We will reconsider when either condition changes.
Will peptides build muscle without training?
No. Recovery peptides amplify what training and nutrition already do; they do not replace either. Patients who pair peptides with consistent strength training and adequate protein see the cleanest results.
Do I need labs before starting?
Yes. Baseline panel typically includes CBC, CMP, IGF-1, fasting glucose/HbA1c, lipid panel, total and free testosterone for men, and a thyroid panel. We repeat the relevant subset at 90 days.
Can peptides help with tendon or joint pain?
This is the area BPC-157 marketing targets. We do not have human RCT evidence to support that use, and we do not prescribe it. For tendon and joint concerns we discuss PRP and structured rehab, which have published human evidence behind them. See our PRP therapy guide.
Talk to a clinician at OC Weight Loss and Medspa
If you want a clinician’s read on which recovery peptide actually fits your labs, training load, and sleep, we can sit down for a no-pressure consult. We offer physician-supervised peptide therapy for Ipamorelin, Sermorelin, CJC-1295, and NAD+ from licensed U.S. compounding pharmacies, with structured labs at baseline and 90 days.
Book a free consultation
Book a Free Consultation